Literature DB >> 3703295

Guillain-Barré syndrome with ophthalmoplegia: clinicopathologic study of the central and peripheral nervous systems, including the oculomotor nerves.

I Dehaene, J J Martin, K Geens, P Cras.   

Abstract

The neuropathologic findings are described in a fatal case of Guillain-Barré syndrome with ophthalmoplegia. Demyelination was found in the oculomotor nerves, which were dissected to the terminal branches in the ocular muscles, and in other peripheral nerves. The CNS was intact except for occasional chromatolytic lesions in some motor nerves.

Entities:  

Mesh:

Year:  1986        PMID: 3703295     DOI: 10.1212/wnl.36.6.851

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Localization of the pathological process in Miller Fisher syndrome.

Authors:  F Barontini; S Di Lollo; S Maurri; P Lambruschini
Journal:  Ital J Neurol Sci       Date:  1992-04

3.  FISHER'S SYNDROME: A CASE REPORT.

Authors:  P K Sharma; D C Gupta; Pvs Rana; S C Bhattacharya
Journal:  Med J Armed Forces India       Date:  2017-06-08

4.  Unilateral third nerve palsy caused by Guillain-Barré Syndrome.

Authors:  Erik K St Louis; Daniel M Jacobson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides.

Authors:  C P O'Leary; J Veitch; W F Durward; A M Thomas; J H Rees; H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

6.  Acute comitant strabismus in anti-GQ1b antibody syndrome.

Authors:  Sun-Uk Lee; Seol-Hee Baek; Hyo-Jung Kim; Jeong-Yoon Choi; Byung-Jo Kim; Ji-Soo Kim
Journal:  J Neurol       Date:  2022-09-29       Impact factor: 6.682

7.  Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts.

Authors:  M Urushitani; F Udaka; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.